Advertisement
Current Issue Cover

Current Issue : September 1, 2010

Entering My Final Year As Editor-in-Chief of JCO. Haller
Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation Cardinale et al
Editorial: Ewer et al
Phase II Trial of Anastrozole Plus Goserelin in the Treatment of Hormone Receptor-Positive, Metastatic Carcinoma of the Breast in Premenopausal Women Carlson et al
Patient-Reported Outcomes in Sentinel Node-Negative Adjuvant Breast Cancer Patients Receiving Sentinel-Node Biopsy or Axillary Dissection: NSABP Protocol B-32 Land et al
Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant FU/LV O'Connell et al
Editorial: Tabernero et al
Impact of Common Medications on Serum Total Prostate-Specific Antigen Levels Chang et al
Fatty Acid Synthase Polymorphisms, Tumor Expression, Body Mass Index, Prostate Cancer Risk, and Survival Nguyen et al
Phase I Trial of the Irreversible ErbB1 and ErbB2 Kinase Inhibitor BIBW 2992 in Patients With Advanced Solid Tumors Yap et al
Special Article: Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting Thomas et al
Biology of Neoplasia: Targeting Breast Cancer Stem Cells Liu et al
 
Alternate international access [more info]
    • Advertisement
    • Advertisement
Society Logo
JOP ASCO Cancer.net ASCO Cancer Foundation